Rheumatoid factor in patients with systemic lupus erythematosus
β Scribed by A. Zoli; L. Altomonte; R. Caricchio; A. Galossi; L. Mirone; F. Scuderi; M. Magaro
- Publisher
- Springer
- Year
- 1996
- Tongue
- English
- Weight
- 253 KB
- Volume
- 15
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We have found subnormal amounts of chemotactic activity in zymosanβtreated sera from 13 of 29 patients with systemic lupus erythematosus (SLE). As an explanation for this abnormality, the presence of a uniquely specific, heatβstable inhibitor of complement (C5)βderived chemotactic activ
## Abstract ## Objective To assess awareness and management of traditional cardiac risk factors (CRFs) in patients with systemic lupus erythematosus (SLE) and physicians. ## Methods SLE patients (n = 110) completed a questionnaire concerning CRFs. Medical records were reviewed blinded to questio